Technical Analysis for SCPH - scPharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 5.83 4.86% 0.27
SCPH closed up 4.86 percent on Friday, June 22, 2018, on 2.06 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical SCPH trend table...

Date Alert Name Type % Chg
Jun 22 Slingshot Bearish Bearish Swing Setup 0.00%
Jun 22 Wide Bands Range Expansion 0.00%
Jun 22 Oversold Stochastic Weakness 0.00%
Jun 21 Bullish Engulfing Bullish 4.86%
Jun 21 Hammer Candlestick Bullish 4.86%
Jun 21 Lizard Bullish Bullish Day Trade Setup 4.86%
Jun 21 Narrow Range Bar Range Contraction 4.86%
Jun 21 Doji - Bullish? Reversal 4.86%
Jun 21 New 52 Week Low Weakness 4.86%
Jun 21 Wide Bands Range Expansion 4.86%

Older signals for SCPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.
Is SCPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.17
52 Week Low 5.21
Average Volume 196,496
200-Day Moving Average 0.0
50-Day Moving Average 10.5606
20-Day Moving Average 8.1175
10-Day Moving Average 6.118
Average True Range 0.8892
ADX 42.65
+DI 12.37
-DI 35.98
Chandelier Exit (Long, 3 ATRs ) 12.1024
Chandelier Exit (Short, 3 ATRs ) 7.8776
Upper Bollinger Band 13.6794
Lower Bollinger Band 2.5556
Percent B (%b) 0.29
BandWidth 137.034801
MACD Line -1.7443
MACD Signal Line -1.609
MACD Histogram -0.1353
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.61
Resistance 3 (R3) 6.58 6.28 6.48
Resistance 2 (R2) 6.28 6.08 6.30 6.44
Resistance 1 (R1) 6.06 5.96 6.17 6.09 6.39
Pivot Point 5.76 5.76 5.82 5.78 5.76
Support 1 (S1) 5.54 5.56 5.65 5.57 5.27
Support 2 (S2) 5.24 5.44 5.26 5.22
Support 3 (S3) 5.02 5.24 5.18
Support 4 (S4) 5.05